EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

1,25-dihydroxyvitamin D mediated hypercalcemia in seminoma

Julianna Sim, Jonathan Irvin, Nezam Altorok

The American Journal of the Medical Sciences · 2025

DOI: 10.1016/j.amjms.2024.08.015 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of the Medical Sciences, 2025. Verfasst von Julianna Sim und 2 weiteren Autor:innen. Beteiligte Einrichtung: The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA. Hauptthemen laut MEDLINE: Hypercalcemia, Seminoma, Vitamin D, Testicular Neoplasms. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypercalcemia has rarely been associated with seminomas. Due to the limited data available, the pathophysiology of hypercalcemia in seminoma has not been established in literature. We present a case of a 59-year-old male who presented with weakness, abdominal fullness, fatigue, constipation, and a 14 lb unintentional weight loss. On initial presentation he was found to be hypercalcemia with calcium of 16.2 mg/dL (normal 8.6-10.3 mg/dL). Subsequently, a metastatic seminoma was discovered with no evidence of bony metastasis. 1,25-dihydroxyvitamin D was elevated at >200 pg/mL (reference 19.9-79.3 pg/mL). PTH was suppressed at 11 pg/mL (reference 12-88 pg/mL). PTHrP was normal at 1.0 pmol/L (reference ≤4.2 pmol/L), 25‑hydroxy vitamin D was low at 22.6 ng/mL (reference 30-100 ng/mL), and phosphorus was normal at 3.9 mg/dL (reference 2.4-4.9 mg/dL). These findings indicate 1,25-dihydroxyvitamin D mediated hypercalcemia of malignancy. Hypercalcemia in seminoma has been reported in 11 cases, that we review in this report. However, few cases present sufficient data to conclude the pathophysiology of hypercalcemia. In all four cases that presented 1,25-hydroxyvitamin D levels, the levels were elevated, suggesting seminomas are associated with 1,25-hydroxyvitamin D mediated hypercalcemia. Interestingly, one case was associated with increased 1,25-hydroxyvitamin D and increased PTHrP levels, suggesting there may be multiple mechanisms of hypercalcemia in seminomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercalcemiaSeminomaVitamin DTesticular NeoplasmsHumansMaleMiddle Aged

Stichwörter der Autor:innen

HypercalcemiaSeminomaVitamin d

Substanzen

1,25-dihydroxyvitamin DVitamin D

Autor:innen und Institutionen

  • The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
  • Department of Internal Medicine, University of Toledo, Toledo, OH, USA. Electronic address: Nezam.Altorok@Utoledo.edu.

Zitieren

APA

Sim, J., Irvin, J., & Altorok, N. (2025). 1,25-dihydroxyvitamin D mediated hypercalcemia in seminoma. The American Journal of the Medical Sciences. https://doi.org/10.1016/j.amjms.2024.08.015

Vancouver

Sim J, Irvin J, Altorok N. 1,25-dihydroxyvitamin D mediated hypercalcemia in seminoma. The American Journal of the Medical Sciences. 2025. doi:10.1016/j.amjms.2024.08.015

BibTeX
@article{Sim2025,
  author = {Sim, Julianna and Irvin, Jonathan and Altorok, Nezam},
  title = {1,25-dihydroxyvitamin D mediated hypercalcemia in seminoma},
  journal = {The American Journal of the Medical Sciences},
  year = {2025},
  doi = {10.1016/j.amjms.2024.08.015}
}
Kostenlos starten →